» Articles » PMID: 35236964

Therapeutically Harnessing Extracellular Vesicles

Overview
Specialty Pharmacology
Date 2022 Mar 3
PMID 35236964
Authors
Affiliations
Soon will be listed here.
Abstract

The field of extracellular vesicle (EV) research has developed rapidly over the last decade from the study of fundamental biology to a subject of significant clinical relevance. The potential of harnessing EVs in the diagnosis and treatment of diseases - including cancer and neurological and cardiovascular disorders - is now being recognized. Accordingly, the applications of EVs as therapeutic targets, biomarkers, novel drug delivery agents and standalone therapeutics are being actively explored. This Review provides a brief overview of the characteristics and physiological functions of the various classes of EV, focusing on their association with disease and emerging strategies for their therapeutic exploitation.

Citing Articles

Prospect of extracellular vesicles in tumor immunotherapy.

Xia W, Tan Y, Liu Y, Xie N, Zhu H Front Immunol. 2025; 16:1525052.

PMID: 40078996 PMC: 11897508. DOI: 10.3389/fimmu.2025.1525052.


Emerging Frontiers in acute kidney injury: The role of extracellular vesicles.

Li S, Zhou L, Huang Y, Tang S Bioact Mater. 2025; 48:149-170.

PMID: 40046015 PMC: 11880721. DOI: 10.1016/j.bioactmat.2025.02.018.


Global requirements for manufacturing and validation of clinical grade extracellular vesicles.

Thakur A, Rai D J Liq Biopsy. 2025; 6:100278.

PMID: 40027307 PMC: 11863704. DOI: 10.1016/j.jlb.2024.100278.


Leveraging nature's nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications.

Chen Y, Douanne N, Wu T, Kaur I, Tsering T, Erzingatzian A Sci Adv. 2025; 11(9):eads5249.

PMID: 40009680 PMC: 11864201. DOI: 10.1126/sciadv.ads5249.


Microfluidic loading of verteporfin into extracellular vesicles for neuroblastoma therapy.

Piunti C, Micheli S, Giancaterino S, Fusco P, Boi C, Cimetta E Lab Chip. 2025; .

PMID: 40007431 PMC: 11862876. DOI: 10.1039/d4lc01103a.


References
1.
Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee J, Lotvall J . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-9. DOI: 10.1038/ncb1596. View

2.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

3.
Raposo G, Nijman H, Stoorvogel W, Liejendekker R, Harding C, Melief C . B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996; 183(3):1161-72. PMC: 2192324. DOI: 10.1084/jem.183.3.1161. View

4.
Meckes Jr D, Shair K, Marquitz A, Kung C, Edwards R, Raab-Traub N . Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A. 2010; 107(47):20370-5. PMC: 2996715. DOI: 10.1073/pnas.1014194107. View

5.
Krejciova Z, Alibhai J, Zhao C, Krencik R, Rzechorzek N, Ullian E . Human stem cell-derived astrocytes replicate human prions in a genotype-dependent manner. J Exp Med. 2017; 214(12):3481-3495. PMC: 5716027. DOI: 10.1084/jem.20161547. View